evans blue has been researched along with uroguanylin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohbayashi, H; Yamaki, KI | 1 |
1 other study(ies) available for evans blue and uroguanylin
Article | Year |
---|---|
Both inhalant and intravenous uroguanylin inhibit leukotriene C4-induced airway changes.
Topics: Administration, Inhalation; Airway Resistance; Animals; Blood Pressure; Bronchoconstriction; Capillary Permeability; Dose-Response Relationship, Drug; Evans Blue; Guinea Pigs; Heart Rate; Injections, Intravenous; Leukotriene C4; Male; Muscle, Smooth, Vascular; Natriuretic Peptides; Peptides; Pulmonary Alveoli; Trachea | 2000 |